Abstract: TH-PO0627
UBDb Modifies the Association of APOL1 Risk Alleles with Kidney Failure in People with HIV
Session Information
- Genetic Diseases of the Kidneys: Complex Kidney Traits
November 06, 2025 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Genetic Diseases of the Kidneys
- 1202 Genetic Diseases of the Kidneys: Complex Kidney Traits
Authors
- Fisher, Molly, Albert Einstein College of Medicine, Bronx, New York, United States
- Nicoletti, Paola, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Peter, Inga, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Crane, Heidi M, University of Washington, Seattle, Washington, United States
- Wyatt, Christina M., Duke University School of Medicine, Durham, North Carolina, United States
- Ross, Michael J., Albert Einstein College of Medicine, Bronx, New York, United States
Group or Team Name
- On behalf of the CFAR Network of Integrated Clinical Systems.
Background
HIV-associated nephropathy (HIVAN) is the kidney disease most strongly linked to APOL1 high-risk genotypes. Ubiquitin D (UBD) is a crucial mediator of kidney injury in HIVAN and the UBD locus is associated with altered APOL1 expression. A UBD haplotype (UBDb) comprising 4 missense SNPs in absolute linkage disequilibrium is most frequent in persons of African ancestry. We examined whether UBDb modifies the association of APOL1 risk alleles with kidney failure in people with HIV (PWH).
Methods
We conducted a case-control study of PWH in CNICS, a multicenter US HIV cohort. Cases (n=199) had CKD stage 5 defined by sustained eGFR <15 mL/min/1.73m2 for >90 days and controls (n=921) had eGFR ≥90ml/min/1.73m2 during follow up. We evaluated 3 UBDb SNPs (rs7757931, rs2076486, rs2076484). We compared UBDb allele frequency in cases vs controls by APOL1 risk allele count. Logistic regression tested whether UBDb modified the association of APOL1 risk alleles with kidney failure. Models were stratified by UBDb and adjusted for age, sex, comorbidities, and HIV RNA. To minimize confounding by population stratification, we restricted analyses to PWH with >70% African ancestry.
Results
Among 1,120 PWH, mean age was 38.8 years, 30.8% were women, 46.8% carried 1 and 12.5% carried 2 APOL1 risk alleles, respectively. In cases, UBDb allele frequency was 39.7%, 50%, and 50.6% in individuals with 0, 1, or 2 APOL1 risk alleles (G1 or G2), respectively. In controls, corresponding allele frequencies were 46.9%, 44.4%, and 41.1%. In stratified models, APOL1 risk alleles were more strongly associated with kidney failure in UBDb carriers, who had over twice the odds of kidney failure vs non-carriers at each APOL1 risk level (aORs [95% CI]: 2.97 [1.69–5.41] vs 1.01 [0.41–2.46] for 1 allele; 18.33 [9.67–34.76] vs 7.42 [2.94–18.77] for 2 alleles; Figure).
Conclusion
In African American PWH, associations of APOL1 risk alleles with kidney failure are stronger in the presence of UBDb, suggesting that it may interact with APOL1 to promote kidney failure.
Funding
- NIDDK Support